Aug 9 (Reuters) - Eli Lilly (NYSE:LLY) and Co LLY.N :
* U.S. COURT OF APPEALS RULES IN FAVOR OF LILLY IN ALIMTA ALTERNATE SALT FORM PATENT LAWSUIT
* RULING CAME IN APPEALS OF U.S. DISTRICT COURT DECISIONS IN CASES OF CO V. DR. REDDY'S LABORATORIES AND CO V. HOSPIRA
* IF PATENT IS ULTIMATELY UPHELD THROUGH ALL REMAINING CHALLENGES, ALIMTA WOULD MAINTAIN U.S. EXCLUSIVITY UNTIL MAY 2022